retatrutide regulatory approval A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity October 27, 2025: U.K. regulators

Magnesium deficiency is considered rare among healthy people eating a balanced diet, but according to NHANES data, around 48 percent of the U.S

lvarez-Mercado AI, Plaza-Diaz J (2022) Dietary Polysaccharides as Modulators of the Gut Microbiota Ecosystem: An Update on Their Impact on Health

Overall, middle-income markets in Asia and Latin America are emerging as key drivers of global market expansion as treatment access improves and physician familiarity with GLP-1 medications increases

It may simply be moving through the body more slowly

These include pathways involved in cell migration, collagen formation, and extracellular matrix organization

Discontinuation rates under 6% even at the highest dose indicate that the gastrointestinal burden, while present, is not prohibitive